Salvesen G S, Catanese J J, Kress L F, Travis J
J Biol Chem. 1985 Feb 25;260(4):2432-6.
Human C1-inhibitor (C1-Inh) forms an equimolar complex with complement proteinase C1s that is resistant to dissociation by sodium dodecyl sulfate. The formation of this stable complex results in the cleavage of a peptide bond near the carboxyl terminus of the inhibitor and, whereas the bulk of C1-Inh remains covalently bound to the light chain of C1s, the postcomplex inhibitor peptide can be isolated under denaturing conditions. We have sequenced the amino-terminal region of this peptide and deduced that it represents the carboxyl-terminal side of the reactive site of C1-Inh. Limited proteolysis of C1-Inh by Crotalus atrox protease results in an active derivative lacking an amino-terminal peptide of 36 residues. Further proteolysis of this derivative with Pseudomonas aeruginosa elastase inactivates the inhibitor and a peptide is released. The amino-terminal sequence of this peptide overlaps with that of the postcomplex peptide and indicates that the residue imparting primary specificity to the inhibitor is arginine.
人C1抑制因子(C1-Inh)与补体蛋白酶C1s形成等摩尔复合物,该复合物对十二烷基硫酸钠的解离具有抗性。这种稳定复合物的形成导致抑制剂羧基末端附近的肽键断裂,虽然大部分C1-Inh仍与C1s的轻链共价结合,但复合物形成后的抑制剂肽可在变性条件下分离出来。我们已对该肽的氨基末端区域进行了测序,并推断它代表C1-Inh反应位点的羧基末端一侧。用矛头蝮蛋白酶对C1-Inh进行有限的蛋白水解会产生一种活性衍生物,该衍生物缺少一个36个残基的氨基末端肽。用铜绿假单胞菌弹性蛋白酶对该衍生物进行进一步的蛋白水解会使抑制剂失活并释放出一个肽。该肽的氨基末端序列与复合物形成后的肽的序列重叠,表明赋予抑制剂主要特异性的残基是精氨酸。